Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Mar 23, 2026

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

396

Primary pulmonary leiomyosarcoma: A case report.

Xiaona Xie1, Yanfan Chen2, Cheng Ding2

  • 1Pulmonary Division, Zhejiang University of Traditional Chinese Medicine Affiliated with Wenzhou Hospital, Wenzhou, Zhejiang 325000, P.R. China.

Oncology Letters
|March 22, 2016
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A weakly supervised deep learning-based recurrence prediction and risk stratification of lung adenocarcinoma from pathology whole-slide images.

BMC cancer·2026
Same author

Autonomic Signature-Driven Anesthesia Depth Monitoring with Biomimetic Wearable ECG and Knowledge Graph-Augmented Deep Networks.

Sensors (Basel, Switzerland)·2026
Same author

Uniportal robotic-assisted left upper lobectomy with pulmonary artery reconstruction for a central lung cancer: a step-by-step surgical technique.

Journal of visualized surgery·2026
Same author

The double-edged sword of tumor-targeted treatment: the influence of targeted therapy on the heart.

Translational cancer research·2026
Same author

Interpretable multitask model for clinical pathology image prediction and interpretation.

NPJ systems biology and applications·2026
Same author

Dens Invaginatus with Apical Periodontitis: A Case Series Illustrating Oehlers Classification-based Management and Genetic Insights.

Journal of endodontics·2026
Same journal

[Expression of Concern] Myricetin inhibits migration and invasion of hepatocellular carcinoma MHCC97H cell line by inhibiting the EMT process.

Oncology letters·2026
Same journal

Identification of neoadjuvant chemoradiotherapy resistance-associated proteins in locally advanced rectal cancer: A pilot study.

Oncology letters·2026
Same journal

Overexpression of EZH2 is associated with clinicopathological parameters and poor prognosis in gliomas.

Oncology letters·2026
Same journal

Methylation of the <i>BMP6</i>, <i>BRCA1</i>, <i>ESR2</i>, <i>GSTP1</i> and <i>TIMP3</i> genes in Mexican women with breast cancer and benign disease.

Oncology letters·2026
Same journal

Pathological fracture of primary lymphoma of bone: A case report on diagnosis and novel surgical management.

Oncology letters·2026
Same journal

Salivary duct carcinoma with heterotopic ossification in the parotid gland: A case report.

Oncology letters·2026
See all related articles

Primary pulmonary leiomyosarcoma (PPL) is a rare lung cancer. This case study details a patient diagnosed with PPL after tumor resection, who unfortunately did not survive chemotherapy.

Area of Science:

  • Oncology
  • Pulmonary Medicine
  • Surgical Pathology

Background:

  • Primary pulmonary leiomyosarcoma (PPL) is an exceptionally rare malignant tumor.
  • PPL can arise from smooth muscle in the lungs, arteries, or bronchi.
  • Clinical presentation of PPL is often non-specific, mimicking other lung tumors.

Purpose of the Study:

  • To report a case of primary pulmonary leiomyosarcoma.
  • To describe the diagnostic and treatment course of a patient with PPL.

Main Methods:

  • Case report of a 48-year-old male patient.
  • Diagnostic workup included identification of a lung mass.
  • Treatment involved bronchoscopic tumor resection followed by chemotherapy.

Main Results:

Keywords:
chemotherapyprimary pulmonary leiomyosarcoma

More Related Videos

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

2.3K
Robotic Enucleation of Esophageal Leiomyoma
04:19

Robotic Enucleation of Esophageal Leiomyoma

Published on: February 20, 2026

366

Related Experiment Videos

Last Updated: Mar 23, 2026

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

396
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

2.3K
Robotic Enucleation of Esophageal Leiomyoma
04:19

Robotic Enucleation of Esophageal Leiomyoma

Published on: February 20, 2026

366
  • The patient was diagnosed with primary pulmonary leiomyosarcoma post-resection.
  • Despite surgical intervention and chemotherapy, the patient's condition deteriorated.
  • The patient succumbed to the disease after two cycles of chemotherapy.

Conclusions:

  • Primary pulmonary leiomyosarcoma is a rare and aggressive malignancy.
  • The prognosis for PPL remains poor, even with current treatment modalities.
  • Further research into effective PPL therapies is warranted.